It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...
Recent comments
5 years 33 weeks ago
14 years 50 weeks ago
14 years 51 weeks ago
14 years 51 weeks ago
15 years 16 weeks ago
15 years 16 weeks ago
15 years 23 weeks ago
15 years 41 weeks ago
16 years 23 weeks ago
16 years 23 weeks ago